Evaluation of response to gemcitabine plus cisplatin-based chemotherapy using positron emission computed tomography for metastatic bladder cancer

Figure 5 Shows the relationship between F-2-fluoro-2-deoxyglucose and tumor cells. A: Molecular imaging targets in oncology; B: Relationship between the death of tumor cells – number of viable tumor cells and F-2-fluoro-2-deoxyglucose positron emission tomography. FDG: Fluorodeoxyglucose; FLT1: Fms-related tyrosine kinase 1; FRGD: frgD gene; F Annexin V: ¹⁸F using N-succinimidyl-4-¹⁸F-fluorobenzoic acid; Cu-ATSM: Copper(II)-diacetyl-bis(N(4)-methylthiosemicarbazone.